Skip to content

Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section

Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section: a Randomized Double-blind Clinical Trial Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04822870
Enrollment
87
Registered
2021-03-30
Start date
2021-03-31
Completion date
2021-05-31
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Iliohypogastric/Ilioinguinal Nerve Block, Quadratus Lumborum Block

Brief summary

The purpose of this study is to compare the analgesic effect of ultrasound-guided quadratus lumborum block and iliohypogastric/ilioinguinal nerve block for postoperative pain management in patients undergoing cesarean section.

Interventions

PROCEDUREquadratus lumborum block

Quadratus lumborum block is an effective nerve block method in post-cesarean section analgesia. It is a relatively new technique that may provide analgesic effect in somatic pain and visceral pain, but has not been verified yet.

PROCEDUREiliohypogastric/ilioinguinal nerve block

Iliohypogastric/ilioinguinal nerve block is a widely used nerve block technique. It can provide somatic analgesia effect in post-cesarean section.

PROCEDUREepidural analgesia

Epidural analgesia is a traditional analgesia method. Epidural morphine can provide effective analgesia but may cause plenty adverse effect.

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* singleton pregnancy * gestation of at least 37 weeks * American Society of Anesthesiologists (ASA) physical status I or II * finish Pfannenstiel section under combined spinal and epidural anesthesia

Exclusion criteria

* pruritus existed before the surgery * allergic to lidocaine, ropivacaine or dexamethasone

Design outcomes

Primary

MeasureTime frameDescription
morphine consumption24 hours postoperativelyEvery parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.

Secondary

MeasureTime frameDescription
hospitalize costat discharge assessed up to 10 daysTotal cost in this hospitalization
effective analgesia time48 hours postoperativelyTime period between finish the intervention and the first time parturient use the patient-controlled intravenous analgesia pump for analgesia supplement.
morphine consumption6 hours postoperativelyEvery parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.
hospital stayat discharge assessed up to 10 daysThe hospitalize length
adverse effect6 hours postoperativelyNausea and vomiting, pruritus, oversedation, respiratory depression and urinary retention are considered adverse effects. The incidence and severity are recorded, 1 score refers to mild, 2 scores refers to moderate, 3 scores refers to severe and treatment needed.
satisfaction score48 hours postoperativelyAsk the patient to evaluate satisfaction score using 0-10. 0 refers totally dissatisfied, 10 refers to the most satisfied
pain score6 hours postoperativelyUse visual analogue scale (VAS) 0-10 to evaluate pain intensity and reflect analgesic effect. 0 refers to completely no pain, 10 refers to the most severe pain she has experienced.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026